U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850414) titled 'Intracameral Levofloxacin Versus Moxifloxacin After Cataract Surgery' on Sept. 24.
Brief Summary: This randomized study aims to compare the safety and efficacy of intracameral levofloxacin versus intracameral moxifloxacin administered at the end of phacoemulsification cataract surgery.
Study Start Date: Sept. 26
Study Type: INTERVENTIONAL
Condition:
Cataract
Postoperative Endophthalmitis
Intervention:
DRUG: Levofloxacin
0.1 mL of preservative-free levofloxacin 0.5% injected into the anterior chamber at the end of phacoemulsification.
DRUG: Moxifloxacin
0.1 mL of preservative-free moxifloxacin 0.5% injected into the anterior ...